Evommune OverviewEvommune Profit Margin
Profitability ratio analysis for EVMN.
Quarterly Profit Margin
N/A
As of Mar 2026
Annual Profit Margin (TTM)
-759.87%
↓ 20.53% YoY
Trailing 12 months ending Mar 2026
Average Profit Margin (Comparison Companies)
Profit Margin History
Profit Margin Comparison
Annual Profit Margin Growth Rate (%)